Tibet Cheezheng Tibetan Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000FM9
CNY
24.75
0.21 (0.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
754.68
397.36
854.83
454.98
629.33
359.37
785.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
754.68
397.36
854.83
454.98
629.33
359.37
785.64
Raw Material Cost
149.74
89.42
160.94
101.53
129.40
82.59
143.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.55
14.87
12.45
15.06
14.34
15.93
17.27
Selling and Distribution Expenses
322.18
204.84
484.74
275.94
278.62
190.93
483.72
Other Expenses
0.44
-0.51
1.10
-0.21
-0.07
-0.56
-0.13
Total Expenditure (Excl Depreciation)
490.86
304.01
669.11
390.39
421.69
283.89
643.30
Operating Profit (PBDIT) excl Other Income
263.8
93.4
185.7
64.6
207.60000000000002
75.5
142.3
Other Income
41.27
-7.42
-2.46
13.88
35.41
26.30
113.34
Operating Profit (PBDIT)
341.93
123.76
218.22
114.21
277.24
136.05
280.81
Interest
14.55
14.87
12.45
15.06
14.34
15.93
17.27
Exceptional Items
24.66
18.67
36.93
15.07
25.03
28.12
8.03
Gross Profit (PBDT)
604.94
307.95
693.89
353.45
499.92
276.78
642.04
Depreciation
36.95
36.95
35.91
35.91
34.28
34.28
26.59
Profit Before Tax
315.09
90.61
206.79
78.31
253.65
113.96
244.99
Tax
29.19
13.93
17.81
8.99
23.48
14.60
31.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
282.71
75.68
188.91
67.69
228.22
97.46
200.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
282.71
75.68
188.91
67.69
228.22
97.46
200.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.64
-0.59
-1.90
-0.41
0.17
1.23
-1.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
284.36
75.09
187.00
67.28
228.39
98.69
199.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,036.45
4,020.67
4,064.38
3,859.90
3,792.57
3,818.23
3,720.33
Earnings per share (EPS)
0.53
0.14
0.36
0.13
0.43
0.18
0.38
Diluted Earnings per share
0.53
0.14
0.36
0.13
0.43
0.18
0.38
Operating Profit Margin (Excl OI)
34.94%
23.71%
21.62%
14.16%
32.98%
21.0%
17.93%
Gross Profit Margin
46.65%
32.1%
28.39%
25.1%
45.75%
41.25%
34.57%
PAT Margin
37.46%
19.05%
22.1%
14.88%
36.26%
27.12%
25.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 19.93% vs 20.05% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 24.52% vs 4.67% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 24.36% vs -1.35% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 1.40% vs -28.50% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Tibet Cheezheng Tibetan Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
754.68
0
754.68
Other Operating Income
0.00
0.00
0.00
Total Operating income
754.68
0
754.68
Raw Material Cost
149.74
0
149.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.55
0
14.55
Selling and Distribution Expenses
322.18
0
322.18
Other Expenses
0.44
0.00
0.44
Total Expenditure (Excl Depreciation)
490.86
0
490.86
Operating Profit (PBDIT) excl Other Income
263.82
0.00
263.82
Other Income
41.27
0
41.27
Operating Profit (PBDIT)
341.93
0
341.93
Interest
14.55
0
14.55
Exceptional Items
24.66
0
24.66
Gross Profit (PBDT)
604.94
0
604.94
Depreciation
36.95
0
36.95
Profit Before Tax
315.09
0
315.09
Tax
29.19
0
29.19
Provisions and contingencies
0
0
0.00
Profit After Tax
282.71
0
282.71
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
282.71
0
282.71
Share in Profit of Associates
0
0
0.00
Minority Interest
1.64
0
1.64
Other related items
0.00
0.00
0.00
Consolidated Net Profit
284.36
0
284.36
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,036.45
0
4,036.45
Earnings per share (EPS)
0.53
0
0.53
Diluted Earnings per share
0.53
0
0.53
Operating Profit Margin (Excl OI)
34.94%
0%
0.00
34.94%
Gross Profit Margin
46.65%
0%
0.00
46.65%
PAT Margin
37.46%
0%
0.00
37.46%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 75.47 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 89.91% vs -53.51% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 19.93% vs 20.05% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 28.44 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 278.70% vs -59.84% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 24.52% vs 4.67% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.07 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 129.19% vs -40.55% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 24.36% vs -1.35% in Jun 2024

Quarterly - Interest
Interest 1.45 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.68% vs 19.20% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 1.40% vs -28.50% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.94%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024